Context Therapeutics Inc. Business Operations Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Master Services Agreement, dated October 8, 2021, by and between Link Immunotherapeutics, Inc. and Just - Evotec Biologics, Inc. (as assigned to the Company on July 9, 2024)
Services Agreements
Context Therapeutics Inc.
Pharmaceuticals
2025
First Amendment to the Development and Manufacturing Services Agreement, dated January 9, 2025, between Lonza Sales AG, Lonza AG and Context Therapeutics Inc
Sales Agreements
Context Therapeutics Inc.
Pharmaceuticals
2025
Sales Agreement, dated as of December 2, 2024, by and between Context Therapeutics Inc. and Leerink Partners LLC
Sales Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2024
Termination Agreement of the Clinical Trial Collaboration and Supply Agreement, dated March 21, 2023 between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group
Termination Agreements
Context Therapeutics Inc.
Pharmaceuticals
2023
Development and Manufacturing Services Agreement, dated November
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Amendment No. 3 to Process Development Agreement
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2022
Clinical Trial Collaboration and Supply Agreement, dated August 1, 2022, by and between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group
Collaboration Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Form of Indemnification Agreement between Context Therapeutics Inc. and its officers and directors
Indemnification Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Amendment No. 2 to Process Development Agreement, dated June 3, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Form of Director Services Agreement
Services Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Amendment No. 1 to Process Development Agreement, dated April 21, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
2021
Process Development Agreement, dated March 6, 2020, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
Development Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2021
Research Collaboration and License Agreement, dated April 6, 2021, between Context Therapeutics LLC and Integral Molecular, Inc
Collaboration Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Voting Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors
Voting Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021